ClinicalTrials.Veeva

Menu

New Strategies of Genetic Study of Patients With Oculocutaneous Albinism (GENALB)

U

University Hospital of Bordeaux

Status

Completed

Conditions

Mutation
Oculocutaneous Albinism

Treatments

Other: Genetic analyzes

Study type

Observational

Funder types

Other

Identifiers

NCT04068961
CHUBX 2010/31

Details and patient eligibility

About

The oculocutaneous albinism is an autosomal recessive condition associated with mutations in 4 genes. In 20% of patients no mutation is identified. The optimization of genetic analysis methods and the search for new genes involved will help improve the diagnosis in these patients.

Full description

The oculocutaneous albinism is an autosomal recessive condition associated with mutations in 4 genes. In 20% of patients no mutation is identified. The optimization of genetic analysis methods and the search for new genes involved will help improve the diagnosis in these patients.

.

Enrollment

64 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

-Oculocutaneous albinism (diagnosis validated by a clinician at the initial genetic consultation and did not show mutations of the TYR, OCA2, TYRP1, SLC45A2 genes)

Exclusion criteria

None

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems